US Patent Issued to Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, National Center for Nanoscience and Technology on Sept. 22 for "Polypeptide that specifically binding to CD123 protein, polypeptide complex, co-delivery system and preparation method and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,016, issued on Sept. 22, was assigned to Institute of Basic Medical Sciences Chinese Academy of Medical Sciences (Beijing) and National Center for Nanoscience and Technology (Beijing).

"Polypeptide that specifically binding to CD123 protein, polypeptide complex, co-delivery system and preparation method and use thereof" was invented by Haiyan Xu (Beijing), Chen Wang (Beijing), Shilin Xu (Beijing), Yanlian Yang (Beijing), Jie Meng (Beijing), Jian Liu (Beijing) and Tao Wen (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention discloses a polypeptide that specifically binding to CD123 protein, a polypeptide complex and a co-delivery sy...